EGFR and hepatocellular carcinoma: For example, in hepatocellular carcinoma (HCC), the recognition protein YTHDF2 directly recognises and binds to the m6A modification site of epidermal growth factor receptor (EGFR), destabilising and degrading it, thereby inhibiting cell proliferation and growth.63